MCID: GST063
MIFTS: 53

Gastric Cancer Risk After H. Pylori Infection malady

Categories: Genetic diseases, Rare diseases, Gastrointestinal diseases, Cancer diseases

Aliases & Classifications for Gastric Cancer Risk After H. Pylori Infection

About this section

Aliases & Descriptions for Gastric Cancer Risk After H. Pylori Infection:

Name: Gastric Cancer Risk After H. Pylori Infection 52
Hereditary Diffuse Gastric Cancer 23 48 24 25 54 70 68
Hdgc 23 48 24 25 54 70
Hereditary Diffuse Gastric Adenocarcinoma 48 25 54
Familial Diffuse Gastric Cancer 48 25 54
Fdgc 48 25 54
Gastric Cancer, Familial Diffuse, with or Without Cleft Lip and/or Palate 52 12
Hereditary Diffuse Cancer of Stomach 48 54
Hereditary Diffuse Gastric Carcinoma 24 27
 
Gastric Cancer, Hereditary Diffuse 52 48
Familial Diffuse Cancer of Stomach 48 54
Breast Cancer, Lobular 70 68
Gastric Cancer Familial Diffuse and Cleft Lip with or Without Cleft Palate 70
E-Cadherin-Associated Hereditary Gastric Cancer 25
Gastric Cancer, Familial Diffuse 48
Gastric Cancer Familial Diffuse 70
Gastric Cancer, Somatic 52
Lbc 70

Characteristics:

Orphanet epidemiological data:

54
hereditary diffuse gastric cancer:
Inheritance: Autosomal dominant; Age of onset: Adult

HPO:

64
gastric cancer risk after h. pylori infection:
Inheritance: autosomal dominant inheritance

GeneReviews:

23
Penetrance: the penetrance of hdgc is incomplete. penetrance analysis has changed several times over the last 13 years. pharoah et al [2001] estimated the cumulative risk for gastric cancer by age 80 years at 67% for men (95% confidence interval [ci], 39-99 years) and 83% for women (95% ci, 58-99 years). females heterozygous for a cdh1 pathogenic variant had an additional cumulative risk for breast cancer of 39% (95% ci, 12-84 years). the combined risk for gastric and breast cancer in women was 90% by age 80 years...


Classifications:



External Ids:

OMIM52 137215
Orphanet54 ORPHA26106
ICD10 via Orphanet31 C16.9

Summaries for Gastric Cancer Risk After H. Pylori Infection

About this section
OMIM:52 Hereditary diffuse gastric cancer is an autosomal dominant cancer predisposition syndrome. Heterozygous CDH1 mutation... (137215) more...

MalaCards based summary: Gastric Cancer Risk After H. Pylori Infection, also known as hereditary diffuse gastric cancer, is related to gastric cancer, somatic and breast cancer, and has symptoms including cleft palate, cleft upper lip and chronic atrophic gastritis. An important gene associated with Gastric Cancer Risk After H. Pylori Infection is CDH1 (Cadherin 1), and among its related pathways are Dendritic Cells Developmental Lineage Pathway and Stabilization and expansion of the E-cadherin adherens junction. Affiliated tissues include breast, bone and liver, and related mouse phenotypes are Decreased viability and cardiovascular system.

Genetics Home Reference:25 Hereditary diffuse gastric cancer (HDGC) is an inherited disorder that greatly increases the chance of developing a form of stomach (gastric) cancer. In this form, known as diffuse gastric cancer, there is no solid tumor. Instead cancerous (malignant) cells multiply underneath the stomach lining, making the lining thick and rigid. The invasive nature of this type of cancer makes it highly likely that these cancer cells will spread (metastasize) to other tissues, such as the liver or nearby bones.

NIH Rare Diseases:48 Hereditary diffuse gastric cancer (HDGC) is an inherited condition that is characterized by an increased risk of developing a specific form of stomach cancer called diffuse gastric cancer. Women with HDGC also have an increased risk for lobular breast cancer. Cancers associated with HDGC generally occur at younger ages than those seen in people who do not have a hereditary predisposition to cancer. HDGC is caused by changes (mutations) in the CDH1 gene and is inherited in an autosomal dominant manner. Management typically involves high-risk cancer screening and/or prophylactic surgeries.    Last updated: 3/17/2015

UniProtKB/Swiss-Prot:70 Breast cancer, lobular: A type of breast cancer that begins in the milk-producing glands (lobules) of the breast. Hereditary diffuse gastric cancer: A cancer predisposition syndrome with increased susceptibility to diffuse gastric cancer. Diffuse gastric cancer is a malignant disease characterized by poorly differentiated infiltrating lesions resulting in thickening of the stomach. Malignant tumors start in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body.

GeneReviews for NBK1139

Related Diseases for Gastric Cancer Risk After H. Pylori Infection

About this section

Diseases related to Gastric Cancer Risk After H. Pylori Infection via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 58)
idRelated DiseaseScoreTop Affiliating Genes
1gastric cancer, somatic33.4CDH1, KRAS
2breast cancer11.3
3ileitis10.3CDH1, IL1B
4diffuse intrinsic pontine glioma10.3CDH1, CTNNA1
5childhood mature teratoma of the ovary10.3CDH1, CTNNA1
6pyloric antrum cancer10.3CDH1, CTNNA1
7breast malignant phyllodes tumor10.3CDH1, CTNNA1
8silo filler's disease10.3IL1B, IL1RN
9mental retardation anophthalmia craniosynostosis10.3IL1B, IL1RN
10warm antibody hemolytic anemia10.3IL1B, IL1RN
11peri-anal fistula10.3IL1B, IL1RN
12non-secretory myeloma10.2IL1B, IL1RN
13cinca syndrome10.2IL1B, IL1RN
14oral candidiasis10.2IL1B, IL1RN
15keloids10.2IL1B, IL1RN
16anaerobic meningitis10.2IL1B, IL1RN
17senile cataract10.2IL1B, IL1RN
18osmotic diarrhea10.2IL1B, IL1RN
19askin's tumor10.2IL1B, IL1RN
20tibialis tendinitis10.2IL1B, IL1RN
21histiocytoid hemangioma10.2IL1B, IL1RN
22lateral sinus thrombosis10.2CDH1, KRAS
23ovarian cancer, somatic10.2CDH1, KRAS
24pediatric supratentorial ependymoma10.2IL1B, IL1RN
25retroperitoneal fibrosis10.2IL1B, IL1RN
26sinusitis10.2IL1B, IL1RN
27partial of retinal vein occlusion10.2IL1B, IL1RN
28mandibular cancer10.2CDH1, IL1B
29hemangioma of lung10.2CDH1, KRAS
30evans' syndrome10.2IL1B, IL1RN
31gastrointestinal neuroendocrine tumor10.2CDH1, KRAS
32lymphangioma10.2IL1B, IL1RN
33periapical granuloma10.2CDH1, KRAS
34pleomorphic lipoma10.1IL1B, IL1RN
35sternum lymphoma10.1IL1B, IL1RN
36dental caries10.1CDH1, KRAS
37early congenital syphilis10.1IL1RN, KRAS
38ovarian wilms' cancer10.1CDH1, KRAS
39xanthomatosis10.1IL1B, IL1RN
40pancreatic somatostatinoma10.1CDH1, KRAS
41plasmacytoma10.1CDH1, IL1B
42richter's syndrome10.1CDH1, KRAS
43palmoplantar keratosis10.1IL1B, IL1RN
44arteritic anterior ischemic optic neuropathy10.1CDH1, KRAS
45trachea sarcoma10.0CDH1, KRAS
46plasma protein metabolism disease10.0CDH1, KRAS
47nasal cavity adenocarcinoma10.0CDH1, KRAS
48hartnup disorder9.9CDH1, KRAS
49paroxysmal nocturnal hemoglobinuria9.9CDH1, KRAS
50eosinophilic gastritis9.9CDH1, IL1B, IL1RN

Graphical network of the top 20 diseases related to Gastric Cancer Risk After H. Pylori Infection:



Diseases related to gastric cancer risk after h. pylori infection

Symptoms & Phenotypes for Gastric Cancer Risk After H. Pylori Infection

About this section

Symptoms by clinical synopsis from OMIM:

137215

Clinical features from OMIM:

137215

Human phenotypes related to Gastric Cancer Risk After H. Pylori Infection:

 64
id Description HPO Frequency HPO Source Accession
1 cleft palate64 rare (5%) HP:0000175
2 cleft upper lip64 rare (5%) HP:0000204
3 chronic atrophic gastritis64 HP:0002582
4 stomach cancer64 HP:0012126

UMLS symptoms related to Gastric Cancer Risk After H. Pylori Infection:


dyspepsia

GenomeRNAi Phenotypes related to Gastric Cancer Risk After H. Pylori Infection according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00381-A-19.4CDH1, KRAS, MAP3K6

MGI Mouse Phenotypes related to Gastric Cancer Risk After H. Pylori Infection according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053858.8CDH1, CTNNA1, IL1B, IL1RN, KRAS
2MP:00107717.8CDH1, CTNNA1, IL1B, IL1RN, KRAS, MAP3K6
3MP:00020067.6CDH1, CTNNA1, IL1B, KRAS, MAP3K6

Drugs & Therapeutics for Gastric Cancer Risk After H. Pylori Infection

About this section

Drugs for Gastric Cancer Risk After H. Pylori Infection (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 55)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Levofloxacinapproved, investigationalPhase 4225100986-85-4149096
Synonyms:
(−
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-Ofloxacin
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(R)-isomer
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-(-)-Ofloxacin
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
)-Ofloxacin
100986-85-4
100986-86-5
28266_FLUKA
28266_SIGMA
AC-7593
AC1L3YF8
Aeroquin
Ambap100986-85-4
BRD-K09471561-001-06-7
BSPBio_002689
C07660
C18H20FN3O4
C18H20FN3O4.H2O
CCRIS 4073
CCRIS 4074
CHEMBL33
CID149096
CPD000466387
Cravit
Cravit (TN)
Cravit Ophthalmic
D08120
DB01137
DR 3354
DR-3355
DR-3355: L-isomer of ofloxacin
DR3355
Elequine
Floxacin
Floxel
Floxin
HMS1922J07
HMS2051G04
HMS2090O10
HMS2093E18
HR 355
HR-355
Iquix
KBio2_002199
KBio2_004767
KBio2_007335
KBio3_001909
 
KBioGR_001605
KBioSS_002199
L-Ofloxacin
L-ofloxacin
L0193
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
LEVOFLOXACIN
LFX
LS-133260
LS-171761
LVX
Leroxacin
Lesacin
Levaquin
Levofloxacin
Levofloxacin (INN)
Levofloxacin [USAN:INN:JAN]
Levofloxacin hydrate
Levofloxacin tablet, suspension or intravenous
Levofloxacine
Levofloxacine [INN-French]
Levofloxacino
Levofloxacino [INN-Spanish]
Levofloxacinum
Levofloxacinum [INN-Latin]
Levokacin
Levox
Levoxacin
MLS000759524
MLS001165709
MLS001423977
MP-376
MolPort-002-885-835
Mosardal
NCGC00178529-01
Nofaxin
Ofloxacin
Ofloxacin S-(-)-form
Oftaquix
Quixin
R-Ofloxacin
RWJ 25213-097
RWJ-25213
Reskuin
S-(-)-Ofloxacin
S1940_Selleck
SAM001246758
SMR000466387
SPBio_001891
SPECTRUM1504260
Spectrum2_001676
Spectrum3_000995
Spectrum4_001123
Spectrum5_001438
Spectrum_001719
Tavanic
Volequin
d-Levofloxacin
2
OfloxacinapprovedPhase 422582419-36-14583
Synonyms:
( -)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure
(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperaz inyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7- -oxo-7H-pyrido(1,2,3-de)- -1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(+/-)-Floxin
118120-51-7 (hydrochloride)
33703_FLUKA
33703_RIEDEL
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
82419-36-1
83380-47-6
85344-55-4
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
AB00513820
AC-7616
AC1L1IHM
AKOS001033517
BB_SC-1252
BPBio1_000345
BRD-A24228527-001-05-9
BRN 3657947
BSPBio_000313
BSPBio_003117
Bactocin
C07321
C18H20FN3O4
CCRIS 5233
CHEBI:7731
CHEMBL4
CID4583
CPD000058192
D00453
DB01165
DEXTROFLOXACINE
DL 8280
DL-8280
DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet, Ofloxacin
Danoflox
DivK1c_000721
EU-0100904
Effexin
Exocin
Exocine
FLOXIN IN DEXTROSE 5%
FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
Floxin (TN)
Floxin otic
Floxstat
Fugacin
HMS1568P15
HMS1921H12
HMS2090F07
HMS2092B10
HMS502E03
HOE 280
Hoe-280
I06-0112
I06-0380
IDI1_000721
Inoflox
KBio1_000721
KBio2_001666
KBio2_004234
KBio2_006802
KBio3_002617
KBioGR_000667
KBioSS_001666
Kinflocin
Kinoxacin
LS-133259
Liflox
Lopac0_000904
Loxinter
MLS000028749
MLS001074203
Marfloxacin
Medofloxine
Mergexin
MolPort-000-422-241
MolPort-000-873-068
NCGC00015772-02
NCGC00015772-10
 
NCGC00094219-01
NCGC00094219-02
NCGC00094219-03
NCGC00094219-04
NCGC00094219-05
NCGC00094219-06
NCGC00178284-01
NCGC00178284-02
NINDS_000721
NSC727071
Novecin
Nufafloqo
O 8757
O-Flox
O8757_SIGMA
OFLX
OFX
ORF 18489
ORF-28489
Obide
Occidal
Ocuflox
Ofcin
Oflin
Oflocee
Oflocet
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
Ofloxacin (JP15/USP/INN)
Ofloxacin Otic
Ofloxacin [USAN:BAN:INN:JAN]
Ofloxacin, (S)-Isomer
Ofloxacina
Ofloxacina [DCIT]
Ofloxacine
Ofloxacine [French]
Ofloxacino
Ofloxacino [Spanish]
Ofloxacinum
Ofloxacinum [Latin]
Ofloxin
Ofus
Onexacin
Operan
Oprea1_242882
Orocin
Otonil
Oxaldin
PT 01
Pharflox
Praxin
Prestwick0_000237
Prestwick1_000237
Prestwick2_000237
Prestwick3_000237
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Ru-43280
S1463_Selleck
SAM002264629
SMR000058192
SPBio_001387
SPBio_002234
SPECTRUM1502044
STK256723
Sinflo
Spectrum2_001464
Spectrum3_001499
Spectrum4_000324
Spectrum5_001063
Spectrum_001186
Tabrin
Taravid
Tariflox
Tarivid
Telbit
Tructum
UNII-A4P49JAZ9H
Uro Tarivid
Viotisone
Visiren
WP-0405
XED
Zanocin
ofloxacin
3
ClarithromycinapprovedPhase 4, Phase 327181103-11-984029
Synonyms:
(14R)-14-Hydroxyclarithromycin
116836-41-0
6-O-Methylerythromycin
6-O-Methylerythromycin a
6-O-methyl erythromycin
81103-11-9
A-56268
AC-6813
AC1L1HJO
AC1L36NJ
AC1NFSZE
AC1NR4MY
AC1NSJWH
AC1O52DV
AC1Q6O1T
ANX-015
Abbotic
Abbott-56268
Adel
Astromen
BB_NC-1450
BIDD:GT0200
BSPBio_003453
Biaxin
Biaxin (TN)
Biaxin HP
Biaxin XL
Biaxin filmtab
Biaxin xl filmtab
Bicrolid
Bio-0020
C06912
C2220
C30H54O11.C9H19NO2
CCRIS 8833
CHEBI:136451
CHEBI:3732
CHEMBL143
CHEMBL1741
CID10147055
CID10328822
CID11814635
CID11828745
CID11969952
CID4663848
CID489010
CID5284534
CID5311050
CID54688
CID6426662
CID84029
CID9810688
CID9811194
CLA
CLARITHROMYCIN
CLM & IL-12
CPD000466382
CRL-1605 & Clarithromycin
CTY
Clacine
Clambiotic
Claribid
Claricide
Clarith
Clarithromycin & Interleukin-12
Clarithromycin (JP15/USP/INN)
Clarithromycin [USAN:INN:BAN:JAN]
Clarithromycin extended release
Clarithromycin suspension or tablets
Clarithromycina
Clarithromycine
Clarithromycine [INN-French]
 
Clarithromycinum
Clarithromycinum [INN-Latin]
Claritromicina
Claritromicina [INN-Spanish]
Clathromycin
Cyllid
Cyllind
D00276
DRG-0099
DivK1c_006655
HMS1922H09
HMS2051G18
HMS2090O11
HMS2094M05
Helas
Heliclar
I05-0074
KBio1_001599
KBio2_000509
KBio2_003077
KBio2_005645
KBio3_002673
KBioGR_001218
KBioSS_000509
Klacid
Klaciped
Klaricid
Klaricid H.P
Klaricid H.P.
Klaricid Pediatric
Klaricid XL
Klarid
Klarin
Klax
Kofron
LMPK04000014
LS-1812
Lactoferrin B & Clarithromycin
Lactoferrin H & Clarithromycin
MLS000759516
MLS001201751
MLS001424066
Mabicrol
Macladin
Maclar
Mavid
MolPort-002-507-425
MolPort-003-845-969
MolPort-005-910-192
MolPort-005-934-146
NCGC00178054-01
NSC643733
Naxy
O(6)-methylerythromycin
SAM001246748
SDP-015
SMR000466382
SPBio_001855
SPECTRUM1504231
STK801952
SpecPlus_000559
Spectrum2_001668
Spectrum3_001667
Spectrum4_000629
Spectrum5_001729
Spectrum_000089
TE-031
TE031
UNII-H1250JIK0A
Veclam
Zeclar
clarithromycin
clarithromycina
hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexame
4
Esomeprazoleapproved, investigationalPhase 4324161796-78-7, 119141-88-74594, 9579578
Synonyms:
( -)-Omeprazole
(-)-Omeprazole
(-)-omeprazole
(S)-(-)-Omeprazole
(S)-(−)-omeprazole
(S)-Omeprazole
(S)-omeprazole
(s)-omeprazole
(−)-omeprazole
119141-88-7
119141-89-8
131959-78-9
172964-80-6
193469-77-1
2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole
2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole
326602-80-6
5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1-methyl-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
73590-58-6
AC-401
AC1L1IIJ
AGI-010
AKOS005066653
AULCER
Antra
Antra MUPS
Audazol
Axagon
BIDD:GT0020
BIDD:GT0189
BPBio1_000425
BRD-A55962179-001-04-9
BSPBio_000385
Belmazol
Bio-0888
C07324
CAS-73590-58-6
CCRIS 7099
CHEBI:50275
CHEBI:519601
CHEBI:7772
CHEMBL1503
CID4594
CID9568614
CID9579578
CPD000058847
Ceprandal
D00455
D07917
DB00338
DB00736
DM-3458
Danlox
Demeprazol
Desec
Dizprazol
Dudencer
Elgam
Emeproton
Emilok
Epirazole
Erbolin
Esomeprazol
Esomeprazole
Esomeprazole (INN)
Esomeprazole Sodium
Esomeprazole [INN:BAN]
Esomeprazolum
Esomperazole
Esopral
Exter
Gasec
Gastrimut
Gastroloc
Gibancer
H 168-68
H 168/68
H-168/68
H168/68
HMS1528I05
HMS1569D07
HMS2052G17
HMS2090E16
HMS2090F11
HSDB 3575
I06-0705
IDI1_032523
InChI=1/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20
Indurgan
Inexium paranova
Inexium paranova (TN)
Inhibitron
Inhipump
LS-185188
LS-7629
Lensor
Logastric
Lomac
Losec
Losec, Omesec, Prilosec, Zegerid, Omeprazole
Lucen
MLS000069373
MLS001076112
MLS001424148
Maybridge4_002645
Mepral
 
Miol
Miracid
MolPort-003-666-741
MolPort-003-807-515
MolPort-003-849-702
MolPort-005-943-880
Mopral
Morecon
NCGC00016925-01
NCGC00016925-02
NCGC00021522-03
NCGC00021522-04
NCGC00021522-05
Nexiam
Nexium
Nexium Control
Nexium IV
Nilsec
Nopramin
Nuclosina
O0359
O104_SIGMA
OMEP
OMZ
Ocid
Olexin
Olit
Omapren
Omebeta
Omebeta 20
Omed
Omegast
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
Omeprazole (JAN/USP/INN)
Omeprazole S-form
Omeprazole [USAN:INN:BAN:JAN]
Omeprazole delayed-release
Omeprazole magnesium
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprazone
Omeprol
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
Ompanyt
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Perprazole
Prazentol
Prazidec
Prazolit
Prestwick0_000493
Prestwick1_000493
Prestwick2_000493
Prestwick3_000493
Prestwick_808
Prilosec
Prilosec (TN)
Prilosec OTC
Procelac
Proclor
Prysma
Ramezol
Regulacid
Result
S1389_Selleck
SAM001246900
SAN-15
SMR000058847
SPBio_002306
STK623746
Sanamidol
Secrepina
TL8005099
Tedec Ulceral
UNII-KG60484QX9
UNII-N3PA6559FT
UPCMLD-DP075
UPCMLD-DP075:001
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
Victrix
ZINC04693574
ZINC04693575
Zefxon
Zegerid
Zepral
Zimor
Zoltum
esomeprazol
esomeprazole
esomeprazolum
omeprazole
Ésoméprazole
5
Amoxicillinapproved, vet_approvedPhase 4, Phase 344126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
BRL-2333
BSPBio_000453
 
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
6
Tetracyclineapproved, vet_approvedPhase 49960-54-85353990
Synonyms:
(-)-Tetracycline
(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
6-Methyl-1,11-dioxy-2-naphthacenecarboxamide
60-54-8
64-75-5 (mono-hydrochloride)
6591-49-7
87128_FLUKA
87128_SIGMA
AC-13151
AC1L1KAT
AC1NQXT7
AC1NRDAM
AC1NS4RQ
AC1NSDX8
AC1NTUT2
AC1NUZHL
AC1O52HS
Abramycin
Abricycline
Achromycin
Achromycin (naphthacene derivative)
Achromycin V
Achromycin, naphthacene derivative
Agromicina
Ambramicina
Ambramycin
Amycin
Anhydrotetracycline
BIDD:GT0653
BPBio1_000242
BSPBio_000220
BSPBio_001950
Bio-tetra
Biocycline
Bristaciclin
Bristaciclin .alpha.
Bristaciclina
Bristacycline
C06570
CHEBI:27902
CHEMBL1440
CID12309720
CID5280962
CID5289435
CID5353990
CID5359245
CID5388997
CID5412
CID5497101
CID6426717
Cefracycline
Cefracycline suspension
Centet (base)
Ciclibion
Copharlan
Criseociclina
Cyclomycin
Cyclopar
Cytome
D00201
DB00759
Democracin
Deschlorobiomycin
DivK1c_000827
Dumocyclin
EINECS 200-481-9
Enterocycline
HMS2090B04
HSDB 3188
Hostacyclin
IDI1_000827
KBio1_000827
KBio2_001514
KBio2_004082
KBio2_006650
KBio3_001450
KBioGR_000783
KBioSS_001514
LS-187078
LS-93869
Lemtrex (base)
Lexacycline
Limecycline
Liquamycin
Liquamycin (Veterinary)
 
Liquamycin, veterinary
MLS000069728
Medocycline
Mericycline
Micycline
MolPort-001-794-633
MolPort-003-983-460
MolPort-005-934-198
NCGC00161665-01
NINDS_000827
NSC 108579
NSC108579
Neocycline
Omegamycin
Orlycycline
Panmycin
Piracaps (base)
Polycycline
Polycycline (VAN)
Polycycline (antibiotic)
Polycycline, antibiotic
Polyotic
Prestwick0_000140
Prestwick1_000140
Prestwick2_000140
Prestwick3_000140
Purocyclina
Resteclin
Robitet
Roviciclina
SK-Tetracycline
SMR000058220
SPBio_001457
SPBio_002159
STOCK1N-42738
Sanclomycine
Solvocin
Spectrum2_001329
Spectrum3_000565
Spectrum4_000352
Spectrum5_001112
Spectrum_001034
Sumycin
Sumycin (TN)
Sumycin syrup
T-125
T3258_SIGMA
Tetra-Co
Tetrabon
Tetrachel
Tetraciclina
Tetraciclina [INN-Spanish]
Tetracycl
Tetracyclin
Tetracycline & VRC3375
Tetracycline (JAN/USP/INN)
Tetracycline (internal use)
Tetracycline Free Base
Tetracycline HCl
Tetracycline I
Tetracycline II
Tetracycline Monohydrochloride
Tetracycline [USAN:INN:BAN:JAN]
Tetracyclinum
Tetracyclinum [INN-Latin]
Tetracyn
Tetradecin
Tetrafil
Tetraverine
Tetrazyklin
Topicycline
Tsiklomistsin
Tsiklomitsin
Tétracycline
UNII-F8VB5M810T
UPCMLD-DP127
UPCMLD-DP127:001
UPCMLD-DP127:002
Veracin
Vetacyclinum
Vetquamycin-324 (free base)
WLN: L E6 C666 BV FV CU GUTTT&J DQ EQ GVZ HQ IN1&1 MQ M1 RQ
component of Tetrastatin
methyl-1,11-dioxo-2-naphthacenecarboxamide
nchembio.273-comp1
nchembio.289-comp1
tetracycline
7
Coal tarapprovedPhase 41918007-45-2
Synonyms:
 
Coal tars
Tar, coal
8
MetronidazoleapprovedPhase 4454443-48-14173
Synonyms:
1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(β-oxyethyl)-2-methyl-5-nitroimidazole
1-Hydroxyethyl-2-methyl-5-nitroimidazole
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
2-Methyl-5-nitro-1-imidazoleethanol
2-Methyl-5-nitroimidazole-1-ethanol
2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-methyl-5-nitroimidazole-1-ethanol
443-48-1
46461_FLUKA
46461_RIEDEL
69198-10-3 (mono-hydrochloride)
99616-64-5
AB00052046
AC-10556
AC1L1HKS
AC1Q2P2Z
AKOS000269646
APMN
ARONIS24285
Acromona
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAS 02983617
BAY-5360
BCBcMAP01_000184
BIDD:GT0107
BPBio1_000004
BRD-K52020312-001-05-2
BRN 0611683
BSPBio_000002
BSPBio_002031
Bayer 5360
Bexon
Bio-0694
CAS-443-48-1
CB-01-14 MMX
CCRIS 410
CHEBI:39845
CHEBI:6909
CHEMBL137
CID4173
CONT
CPD000058175
Caswell No. 579AA
Clont
D00409
DB00916
Danizol
Deflamon
Deflamon-wirkstoff
DivK1c_000007
EINECS 207-136-1
EPA Pesticide Chemical Code 120401
Efloran
Elyzol
Entizol
Eumin
FLAGYL I.V. RTU IN PLASTIC CONTAINER
Flagemona
Flagesol
Flagil
Flagyl
Flagyl (TN)
Flagyl 375
Flagyl Er
Flagyl I.V.
Flagyl I.V. RTU
Flegyl
Florazole
Fossyol
Giatricol
Ginefla vir
Gineflavir
HMS1568A04
HMS1920N19
HMS2051G07
HMS2090B19
HMS2091F14
HMS500A09
HMS547C19
HSDB 3129
I14-0667
IDI1_000007
IDR-90105
KBio1_000007
KBio2_001515
KBio2_004083
KBio2_006651
KBio3_001531
KBioGR_000559
KBioSS_001515
Klion
Klont
LS-1264
M0924
M1547_SIGMA
M3761_FLUKA
M3761_SIGMA
M9036_SIGMA
METRO I.V
METRONIDAZOLE USP
MLS000028590
MLS000758286
Maybridge1_001999
Meronidal
Methronidazole
Methyl-5-nitroimidazole-1-ethanol
 
Metric
Metric 21
Metro Cream
Metro Gel
Metro I.V.
Metro I.V. In Plastic Container
MetroCream
MetroGel
MetroGel-Vaginal
MetroLotion
Metrodzhil
Metrogel-vaginal (TN)
Metrogyl
Metrolag
Metrolyl
Metromidol
Metronidaz
Metronidazol
Metronidazol [INN-Spanish]
Metronidazole (JP15/USP/INN)
Metronidazole Benzoate
Metronidazole Monohydrochloride
Metronidazole Phosphoester
Metronidazole [USAN:INN:BAN:JAN]
Metronidazole in Plastic Container
Metronidazolo
Metronidazolo [DCIT]
Metronidazolum
Metronidazolum [INN-Latin]
Metrotop
Metrozine
Metryl
Mexibol
Mexibol 'silanes'
MolPort-000-141-892
MolPort-002-502-101
Monagyl
Monasin
NCGC00016446-01
NCGC00016446-02
NCGC00022059-03
NCGC00022059-04
NCGC00022059-05
NCIOpen2_000337
NIDA
NINDS_000007
NSC 50364
NSC 69587
NSC-50364
NSC50364
NSC69587
Nalox
Nidagel
Noritate
Noritate (TN)
Novonidazol
Orvagil
Prestwick0_000081
Prestwick1_000081
Prestwick2_000081
Prestwick3_000081
Prestwick_334
Protostat
RP 8823
RP-8823
Rathimed
Rosased
S1907_Selleck
SAM001247010
SBB041018
SC 10295
SMP1_000189
SMR000058175
SPBio_000666
SPBio_001941
SPECTRUM1500412
STK177359
Sanatrichom
Satric
Spectrum2_000883
Spectrum3_000506
Spectrum4_000060
Spectrum5_001289
Spectrum_001035
Takimetol
Trichazol
Trichex
Tricho cordes
Tricho-gynaedron
Trichocide
Trichomol
Trichomonacid 'pharmachim'
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
UNII-140QMO216E
Vagilen
Vagimid
Vandazole
Vertisal
WLN: T5N CNJ A2Q B1 ENW
WLN: T5N CNJA2Q B1 ENW
WLN: T6NTJ DQ ANU1- ET5N CNJ A1 BNW
Wagitran
ZERO/004064
ZINC00113442
Zadstat
Zidoval
giniflavir
metronidazole
neo-Tric
9
Guaifenesinapproved, vet_approvedPhase 461693-14-13516
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
Amonidren
Amonidrin
Aresol
Benylin-E
Bronchol
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
 
Glycerylguaiacol
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphesin
Hustosil
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
O-Methoxyphenyl glyceryl ether
Organidin NR
Pneumomist
Propanosedyl
Reduton
Robitussin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
guaiphenesin
p-Cresyl acetate
10
Furazolidoneapproved, vet_approvedPhase 41067-45-83435, 5323714
Synonyms:
3-(((5-Nitro-2-furanyl)methylene)amino)-2-oxazolidinone
3-((5-Nitrofurfurylidene)amino)-2-Oxazolidinone
3-((5-Nitrofurfurylidene)amino)-2-oxazolidinone
3-((5-Nitrofurfurylidene)amino)-2-oxazolidone
3-((5-Nitrofurfurylidine)amino)-2-Oxazolidinone
3-((5-Nitrofurylidene)amino)-2-oxazolidone
3-(5'-Nitrofurfuralamino)-2-oxazolidone
3-(5-Nitrofurfurylideneamino)-2-oxazolidinone
3-[(5-Nitrofurfurylidene)amino]-2-oxazolidinone
3-[(5-Nitrofurfurylidene)amino]-2-oxazolidone
3-[(5-Nitrofurfurylidine)amino]-2-Oxazolidinone
3-[(5-Nitrofurylidene)amino]-2-oxazolidone
3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one
3-[[(5-Nitro-2-furanyl)methylene]-amino]-2-oxazolidinone
3-[[(5-Nitro-2-furanyl)methylene]amino]-2-Oxazolidinone
3-[[(5-Nitro-2-furanyl)methylene]amino]-2-oxazolidinone
3-[[(5-Nitro-2-furanyl)methylene]amino]-2-oxazolidinone, 9CI
3-{[(5-Nitro-2-furanyl)methylene]amino}-2-oxazolidinone
3-{[(5-nitro-2-furanyl)methylene]amino}-2-oxazolidinone
3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one
3-{[(E)-(5-nitrofuran-2-yl)methylidene]amino}-1,3-oxazolidin-2-one
46297_FLUKA
46297_RIEDEL
5-Nitro-N-(2-oxo-3-oxazolidinyl)-2-furanmethanimine
67-45-8
8023-25-4
8027-73-4
AB00443658
AC-11695
AC1NT43A
AI3-50103
AKOS001678302
BIDD:GT0182
BPBio1_000743
BRD-K10647544-001-02-0
BRD-K11756522-001-03-2
BSPBio_000675
BSPBio_002052
Bifuron
Bio-0354
C07999
CCRIS 1540
CHEBI:5195
CHEMBL1103
CID5323714
Corizium
Coryzium
D005664
D00830
DB00614
Diafuron
EINECS 200-653-3
Enterotoxon
F-8900
F9505_SIGMA
FZL
Fiurox aerosol powder
Furall
Furaxon
Furaxone
Furazol
Furazolidine
Furazolidon
Furazolidona
Furazolidona [INN-Spanish]
Furazolidone
Furazolidone (USP/INN)
Furazolidone [INN:BAN]
 
Furazolidonum
Furazolidonum [INN-Latin]
Furazolum
Furazon
Furidon
Furovag
Furox
Furox Aerosol Powder (Veterinary)
Furoxal
Furoxane
Furoxon
Furoxone
Furoxone (TN)
Furoxone Liquid
Furoxone Swine Mix
Furoxone swine mix
Furozolidine
Giardil
Giarlam
HMS1920O22
HMS2091H03
HMS500E07
HSDB 7036
I05-0078
IDI1_000085
InChI=1/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5
LS-100676
Medaron
MolPort-000-836-892
N-(5-Nitro-2-furfurylidene)-3-amino-2-oxazolidone
N-(5-Nitro-2-furfurylidene)-3-aminooxazolidine-2-one
NCGC00095304-01
NCGC00095304-02
NCGC00095304-03
NCGC00095304-04
NF 180 custom mix ten
NF-180
NSC 6469
NSC6469
Neftin
Nicolen
Nifulidone
Nifuran
Nifurazolidone
Nifurazolidonum
Nitrofurazolidone
Nitrofurazolidonum
Nitrofuroxon
Optazol
Ortazol
Prestwick2_000808
Prestwick3_000808
Puradin
Roptazol
SPECTRUM1500309
STK388219
Sclaventerol
Spectrum5_000742
Tikofuran
Topazone
Trichofuron
Tricofuron
Tricoron
Trifurox
UNII-5J9CPU3RE0
USAF EA-1
Usaf ea-1
Viofuragyn
furazolidone
11
Tinidazoleapproved, investigationalPhase 42119387-91-85479
Synonyms:
 
Timidazole
12Anti-Bacterial AgentsPhase 4, Phase 310884
13Antibiotics, AntitubercularPhase 46972
14Anti-Ulcer AgentsPhase 4, Phase 31767
15Anti-Infective AgentsPhase 4, Phase 321402
16AntacidsPhase 4, Phase 31767
17
Proton pump inhibitorsPhase 4, Phase 31080
Synonyms:
 
PPIs
18Cytochrome P-450 CYP3A InhibitorsPhase 4, Phase 31666
19Antiprotozoal AgentsPhase 41986
20Antiparasitic AgentsPhase 42127
21Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 33822
22Gastrointestinal AgentsPhase 4, Phase 38109
23Renal AgentsPhase 4732
24Topoisomerase InhibitorsPhase 44945
25Cytochrome P-450 CYP1A2 InhibitorsPhase 4553
26Alkylating AgentsPhase 44694
27Anti-Infective Agents, LocalPhase 41785
28Antitubercular AgentsPhase 41272
29Chlorpheniramine, phenylpropanolamine drug combinationPhase 4616
30
Lansoprazoleapproved, investigationalPhase 3207103577-45-33883
Synonyms:
103577-45-3
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
A 65006
A-65006
AB00052388
ABT-006
AC1L1GX8
AG 1749
AG-1749
Abbot Brand of Lansoprazole
Agopton
Almirall Brand of Lansoprazole
Amarin
Aprazol
BIDD:GT0006
BPBio1_001194
BRD-A49172652-001-05-7
BRN 4333393
BSPBio_001084
BSPBio_001830
Bamalite
Bio-0824
Biuret
Biuret Gr
Biuret Reagent
Biuret Reagent Solution
Blason
C058687
C16H14F3N3O2S
CAS-103577-45-3
CG-4801
CHEBI:6375
CHEMBL480
CID3883
CPD000058469
Compraz
D00355
DB00448
Dakar
DivK1c_000920
EU-0100709
FT-0082011
HMS1571G06
HMS1922M04
HMS2052F05
HMS2093M07
HMS502N22
HSDB 7204
Hoechst Brand of Lansoprazole
Hormona Brand of Lansoprazole
I06-0018
IDI1_000920
Ilsatec
KBio1_000920
KBio2_002060
KBio2_004628
KBio2_007196
KBio3_001330
KBioGR_001491
KBioSS_002060
Ketian
L 8533
L8533_SIGMA
LS-33080
Lancid
Lanfast
Lanproton
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
Lansoprazole
Lansoprazole (JAN/USP/INN)
Lansoprazole [USAN:BAN:INN]
Lansoprazole [Usan:Ban:Inn]
Lansoprazolum
Lansoprazolum [INN-Latin]
Lansox
Lanston
 
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
Lanzor
Lanzul
Lapraz
Lasoprol
Lederle Brand of Lansoprazole
Limpidex
Linamarin
Lopac-L-8533
Lopac0_000709
MLS-0003247.0001
MLS000069705
MLS000759405
MLS001074170
Mesactol
MolPort-003-666-508
MolPort-006-394-760
Monolitum
NCGC00015615-01
NCGC00015615-02
NCGC00015615-03
NCGC00015615-06
NCGC00015615-11
NCGC00023826-03
NCGC00023826-04
NCGC00023826-05
NCGC00023826-06
NCGC00023826-07
NINDS_000920
Ogast
Ogastro
Opiren
Prestwick0_001072
Prestwick1_001072
Prestwick2_001072
Prestwick3_001072
PrevOnco
Prevacid
Prevacid (TN)
Prevacid I.V
Prevacid I.V.
Prevacid Iv
Prevacid SoluTab
Prevacid Solutab
Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole
Prevpac
Prezal
Pro Ulco
Promeco
Promeco Brand of Lansoprazole
Promp
Prosogan
S1354_Selleck
SAM001246544
SMR000058469
SPBio_000488
SPBio_002992
SPECTRUM1503926
STK621169
Salvar Brand of Lansoprazole
Spectrum2_000444
Spectrum3_000295
Spectrum4_000856
Spectrum5_001521
Spectrum_001580
Suprecid
TAK 390MR
TAK-390MR
TAK390MR
TAP Brand of Lansoprazole
TL8000155
Takeda Brand of Lansoprazole
Takepron
Tecnobio Brand of Lansoprazole
UNII-0K5C5T2QPG
Ulpax
Vinas Brand of Lansoprazole
Wyeth Brand of Lansoprazole
Zoprol
Zoton
lansoprazole
lansoprazole sulphone
lanzoprazole
31VaccinesPhase 36428
32
DexlansoprazolePhase 3207138530-94-6, 103577-45-39578005
Synonyms:
138530-94-6
CHEMBL1201863
CID9578005
D08903
Dexlansoprazole (INN/USAN)
KS-1075
 
Kapidex
MolPort-002-885-834
T 168390
TAK 390
UNII-UYE4T5I70X
ZINC00599734
dexlansoprazole
33
nivolumabapprovedPhase 2326946414-94-4
Synonyms:
BMS-936558
 
MDX-1106
ONO-4538
nivolumab
34ImmunoglobulinsPhase 26045
35AntibodiesPhase 26045
36Antibodies, MonoclonalPhase 23795
37
Simvastatinapproved51079902-63-954454
Synonyms:
(+)-Simvastatin
(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate
2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
79902-63-9
AC-1530
AC1L1H1F
AKOS005111006
ARONIS24119
BCBcMAP01_000007
BIDD:GT0769
BPBio1_001001
BRD-K22134346-001-05-8
BRN 4768037
BSPBio_000909
BSPBio_002337
Bio-0672
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
C25H38O5
CCRIS 7558
CHEBI:9150
CHEMBL1064
CID54454
CPD000718785
Cholestat
Coledis
Colemin
Corolin
D00434
D019821
DRG-0320
Denan
DivK1c_006991
Eucor
HMS1570N11
HMS1922H13
HMS2089D12
HMS2093E06
HSDB 7208
InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1
KBio1_001935
KBio2_002197
KBio2_004765
KBio2_007333
KBio3_001557
KBioGR_001244
KBioSS_002197
KS-1113
Kolestevan
L 644128-000U
LS-46264
Labistatin
Lipex
Lipinorm
Liponorm
Lipovas
Lodales
MK 0733
MK 733
MK-0733
MK-733
MK733
MLS001304029
MLS001333077
MLS001333078
 
MLS002154038
Medipo
Modutrol
MolPort-002-507-345
MolPort-002-885-862
NCGC00017324-01
NCGC00017324-02
NCGC00017324-03
Nivelipol
Nor-Vastina
Pantok
Pepstatin
Prestwick0_000865
Prestwick1_000865
Prestwick2_000865
Prestwick3_000865
Prestwick_171
Rechol
Rendapid
S1792_Selleck
S6196_SIGMA
SAM002589969
SMR000718785
SPBio_001881
SPBio_002830
SPECTRUM1504236
STK801938
Simcor
Simovil
Simvast CR
Simvastatin
Simvastatin & Primycin
Simvastatin (JAN/USP/INN)
Simvastatin [USAN:INN:BAN]
Simvastatin [Usan:Ban:Inn]
Simvastatin lactone
Simvastatin, Compactin
Simvastatina
Simvastatina [Spanish]
Simvastatine
Simvastatine [French]
Simvastatinum
Simvastatinum [Latin]
Simvotin
Sinvacor
Sinvascor
Sivastin
SpecPlus_000895
Spectrum2_001671
Spectrum3_000669
Spectrum4_000632
Spectrum5_001428
Spectrum_001717
Statin
Synvinolin
TNP00259
UNII-AGG2FN16EV
Valemia
Vasotenal
Velostatin
Vytorin
ZINC03780893
Zocor
Zocor (TN)
Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin
Zocord
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta
nchembio790-comp16
simvastatin
38
Ironapproved11237439-89-623925
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
ATW 230
ATW 432
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
C00023
C3518_SIAL
C3518_SIGMA
CCRIS 1580
CHEBI:18248
CID23925
Carbonyl iron
Copy Powder CS 105-175
D007501
DB01592
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Diseases (animal), iron overload
Diseases, iron overload
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
 
Ed-In-Sol
Eisen
Electrolytic iron
F 60 (metal)
FE
FT 3 (element)
Fe
Fe-40
Fe1+
Feronate
Ferretts
Ferro-Caps
Ferro-Time
Ferrousal
Ferrovac E
Ferrum
Ferrum metallicum
GS 6
HF 2 (element)
HL (iron)
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Hemocyte
Hierro
Hoeganaes ATW 230
Hoeganaes EH
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron powder
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(III) nitrate solution
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
Iron, reduced
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh-1M3
PZh-2
PZh1M1
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Reduced iron
Remko
SUY-B 2
Siderol
UNII-E1UOL152H7
Vitedyn-Slo
Yieronia
fer
ferrous iron
hierro
39
Omeprazoleapproved, investigational, vet_approved33773590-58-64594
Synonyms:
( -)-Omeprazole
(-)-Omeprazole
(S)-(-)-Omeprazole
(S)-Omeprazole
119141-89-8
131959-78-9
172964-80-6
2,3,5-Trimethylpyridine/Omeprazole
2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole
2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole
5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
73590-58-6
AC-401
AC1L1IIJ
AGI-010
AKOS005066653
AULCER
Antra
Antra MUPS
Audazol
Aulcer
Axagon
BIDD:GT0189
BPBio1_000425
BRD-A55962179-001-04-9
BSPBio_000385
Belmazol
Bio-0888
C07324
CAS-73590-58-6
CCRIS 7099
CHEBI:519601
CHEBI:7772
CHEMBL1503
CID4594
CPD000058847
Ceprandal
D00455
DB00338
DB00736
DM-3458
Danlox
Demeprazol
Desec
Dizprazol
Dudencer
Elgam
Emeproton
Emilok
Epirazole
Erbolin
Esomeprazole
Esomperazole
Esopral
Exter
Gasec
Gastrimut
Gastroloc
Gibancer
H 168-68
H 168/68
H-168/68
H168/68
HMS1528I05
HMS1569D07
HMS2052G17
HMS2090E16
HMS2090F11
HSDB 3575
I06-0705
IDI1_032523
Indurgan
Inhibitron
Inhipump
LS-7629
Lensor
Logastric
Lomac
Losec
Losec, Omesec, Prilosec, Zegerid, Omeprazole
Lucen
MLS000069373
MLS001076112
MLS001424148
Maybridge4_002645
Mepral
Miol
Miracid
MolPort-003-666-741
MolPort-003-807-515
MolPort-003-849-702
Mopral
Morecon
NCGC00016925-01
 
NCGC00016925-02
NCGC00021522-03
NCGC00021522-04
NCGC00021522-05
Nexiam
Nexium
Nexium IV
Nilsec
Nopramin
Nuclosina
O0359
O104_SIGMA
OMEP
OMP
OMZ
Ocid
Olexin
Olit
Omapren
Omebeta
Omebeta 20
Omed
Omegast
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
Omeprazole
Omeprazole (JAN/USP/INN)
Omeprazole Pellets
Omeprazole [USAN:INN:BAN:JAN]
Omeprazole delayed-release
Omeprazole magnesium
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprazone
Omeprol
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
Ompanyt
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Prazentol
Prazidec
Prazolit
Prestwick0_000493
Prestwick1_000493
Prestwick2_000493
Prestwick3_000493
Prestwick_808
Prilosec
Prilosec (TN)
Prilosec OTC
Procelac
Proclor
Prysma
Ramezol
Regulacid
Result
S1389_Selleck
SAM001246900
SAN-15
SMR000058847
SPBio_002306
STK623746
Sanamidol
Secrepina
TL8005099
Tedec Ulceral
UNII-KG60484QX9
UPCMLD-DP075
UPCMLD-DP075:001
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
Victrix
Zefxon
Zegerid
Zepral
Zimor
Zoltum
esomeprazol
omeprazole
40Anticholesteremic Agents1983
41Antimetabolites11774
42Lipid Regulating Agents2702
43Hypolipidemic Agents2721
44Hydroxymethylglutaryl-CoA Reductase Inhibitors1956
45Peripheral Nervous System Agents22776
46Analgesics, Non-Narcotic6260
47Analgesics11287
48Gastrins39
49Cyclooxygenase Inhibitors2778
50Anti-Inflammatory Agents10355

Interventional clinical trials:

(show all 26)
idNameStatusNCT IDPhase
1Community-based Helicobacter Pylori EradicationUnknown statusNCT00155389Phase 4
2Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori InfectionCompletedNCT00656968Phase 4
3Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer MortalityRecruitingNCT02047994Phase 4
4Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori TreatmentNot yet recruitingNCT02988089Phase 4
5A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese ChildrenCompletedNCT02302170Phase 3
6Gastric Cancer Prevention in the Family Members by Helicobacter Pylori EradicationActive, not recruitingNCT01678027Phase 3
7Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersNot yet recruitingNCT02978625Phase 2
8Gastropanel for Gastric Atrophy and Cancer Risk AssessmentUnknown statusNCT02114411
9Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase PathwayUnknown statusNCT00498134
10Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric CancerUnknown statusNCT01813994
11The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After AntrectomyUnknown statusNCT00441831
12Effects of Dietary Heme/Non-heme Iron and Helicobacter Pylori (Hp) Infection on Maternal Iron-deficiency Anemia and Fetal Growth OutcomesUnknown statusNCT01071759
13The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric NeoplasmCompletedNCT02682446
14Long-term Follow-up Prognosis of Atrophic Gastritis After 3 YearsCompletedNCT01824953
15Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)CompletedNCT00212225
16New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric AtrophyCompletedNCT02597517
17Primary Antimicrobial Resistance Patterns of Austrian Helicobacter Pylori Clinical IsolatesCompletedNCT02925091
18Endomicroscopy and Gastric MALT-lymphomaCompletedNCT01583699
19Early Onset and Familial Gastric Cancer RegistryRecruitingNCT00582257
20Hereditary Colorectal and Associated Tumor Registry StudyRecruitingNCT00633607
21Reinfection After Eradication of Helicobacter Pylori InfectionRecruitingNCT02674802
22Volatile Markers in Digestive CancerRecruitingNCT02332213
23Helicobacter Pylori Eradication to Prevent Gastric CancerActive, not recruitingNCT01133951
24Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer RiskNot yet recruitingNCT02624271
25Helicobacter Pylori Genome ProjectNot yet recruitingNCT02788214
26Linked Color Imaging/Magnifying Blue Laser Imaging to Differentiate H. Pylori Associated Gastritis and Gastric AtrophyNot yet recruitingNCT02724280

Search NIH Clinical Center for Gastric Cancer Risk After H. Pylori Infection

Genetic Tests for Gastric Cancer Risk After H. Pylori Infection

About this section

Genetic tests related to Gastric Cancer Risk After H. Pylori Infection:

id Genetic test Affiliating Genes
1 Hereditary Diffuse Gastric Cancer27 24 CDH1

Anatomical Context for Gastric Cancer Risk After H. Pylori Infection

About this section

MalaCards organs/tissues related to Gastric Cancer Risk After H. Pylori Infection:

36
Breast, Bone, Liver, Small intestine, Lymph node, Testes, Skin

Publications for Gastric Cancer Risk After H. Pylori Infection

About this section

Variations for Gastric Cancer Risk After H. Pylori Infection

About this section

UniProtKB/Swiss-Prot genetic disease variations for Gastric Cancer Risk After H. Pylori Infection:

70
id Symbol AA change Variation ID SNP ID
1CDH1p.Asp244GlyVAR_008712
2CDH1p.Val487AlaVAR_008713
3CDH1p.Val832MetVAR_023358rs35572355

Clinvar genetic disease variations for Gastric Cancer Risk After H. Pylori Infection:

5 (show all 34)
id Gene Variation Type Significance SNP ID Assembly Location
1CDH1NM_004360.4(CDH1): c.2131C> G (p.Leu711Val)SNVPathogenicrs121964871GRCh37Chr 16, 68857496: 68857496
2CDH1CDH1, 1-BP INS, 2382CinsertionPathogenicChr na, -1: -1
3CDH1NM_004360.4(CDH1): c.2095C> T (p.Gln699Ter)SNVPathogenicrs121964874GRCh37Chr 16, 68857460: 68857460
4CDH1CDH1, IVS1AS, A-G, -2SNVPathogenicChr na, -1: -1
5CDH1NM_004360.4(CDH1): c.59G> A (p.Trp20Ter)SNVPathogenicrs121964875GRCh37Chr 16, 68772210: 68772210
6CDH1NM_004360.4(CDH1): c.70G> T (p.Glu24Ter)SNVPathogenicrs121964876GRCh37Chr 16, 68772221: 68772221
7CDH1NM_004360.4(CDH1): c.1792C> T (p.Arg598Ter)SNVPathogenicrs121964877GRCh37Chr 16, 68855984: 68855984
8CDH1CDH1, 1-BP INS, 1711GinsertionPathogenicChr na, -1: -1
9CDH1CDH1, 1-BP INS, 1588CinsertionPathogenicChr na, -1: -1
10CDH1NM_004360.4(CDH1): c.1901C> T (p.Ala634Val)SNVLikely pathogenic, Pathogenicrs121964878GRCh37Chr 16, 68856093: 68856093
11CDH1NM_004360.4(CDH1): c.2494G> A (p.Val832Met)SNVLikely pathogenic, Pathogenicrs35572355GRCh37Chr 16, 68867247: 68867247
12CDH1nsv513771deletionPathogenicChr na, -1: -1
13CDH1CDH1, 828-BP DEL/3-BP INS, EX16indelPathogenicChr na, -1: -1
14CDH1NM_004360.4(CDH1): c.1565+1G> ASNVPathogenicrs587780113GRCh38Chr 16, 68815760: 68815760
15CDH1NM_004360.4(CDH1): c.715G> A (p.Gly239Arg)SNVLikely pathogenic, Pathogenicrs587780537GRCh37Chr 16, 68844127: 68844127
16CDH1NM_004360.4(CDH1): c.1003C> T (p.Arg335Ter)SNVPathogenicrs587780784GRCh38Chr 16, 68811854: 68811854
17CDH1NM_004360.4(CDH1): c.2287G> T (p.Glu763Ter)SNVPathogenicrs587780787GRCh38Chr 16, 68828296: 68828296
18CDH1NM_004360.4(CDH1): c.2064_2065delTG (p.Cys688Terfs)deletionPathogenicrs587781276GRCh38Chr 16, 68823526: 68823527
19CDH1NM_004360.4(CDH1): c.1118C> T (p.Pro373Leu)SNVLikely pathogenicrs587782359GRCh37Chr 16, 68846147: 68846147
20CDH1NM_004360.4(CDH1): c.1023T> G (p.Tyr341Ter)SNVPathogenicrs587776398GRCh38Chr 16, 68812149: 68812149
21CDH1NM_004360.4(CDH1): c.187C> T (p.Arg63Ter)SNVPathogenicrs587783047GRCh38Chr 16, 68801693: 68801693
22CDH1NM_004360.4(CDH1): c.2398delC (p.Arg800Alafs)deletionPathogenicrs587783048GRCh38Chr 16, 68829756: 68829756
23CDH1NM_004360.4(CDH1): c.1137G> A (p.Thr379=)SNVPathogenicrs587783050GRCh38Chr 16, 68812263: 68812263
24CDH1NM_004360.4(CDH1): c.1008G> T (p.Glu336Asp)SNVPathogenicrs267606712GRCh37Chr 16, 68845762: 68845762
25CDH1NM_004360.4(CDH1): c.2430delT (p.Phe810Leufs)deletionLikely pathogenic, Pathogenicrs786203752GRCh37Chr 16, 68863691: 68863691
26CDH1NM_004360.4(CDH1): c.388-?_*2042+?deldeletionPathogenicChr na, -1: -1
27CDH1NM_004360.4(CDH1): c.504delA (p.Gly169Alafs)deletionPathogenicrs864622655GRCh38Chr 16, 68808540: 68808540
28CDH1NM_004360.4(CDH1): c.1064delT (p.Leu355Terfs)deletionPathogenicrs863224505GRCh37Chr 16, 68846093: 68846093
29CDH1NM_004360.4(CDH1): c.1220delCdeletionPathogenicrs886037822GRCh38Chr 16, 68813395: 68813395
30CDH1NM_004360.4(CDH1): c.1137+1G> ASNVPathogenicrs876660771GRCh37Chr 16, 68846167: 68846167
31CDH1NM_004360.4(CDH1): c.220C> T (p.Arg74Ter)SNVPathogenicrs876658932GRCh37Chr 16, 68835629: 68835629
32CDH1NM_004360.4(CDH1): c.360dupG (p.His121Alafs)duplicationPathogenicrs878854690GRCh37Chr 16, 68835769: 68835769
33CDH1NM_004360.4(CDH1): c.3G> A (p.Met1Ile)SNVLikely pathogenicrs878854691GRCh37Chr 16, 68771321: 68771321
34CDH1NM_004360.4(CDH1): c.832+1G> TSNVLikely pathogenicrs878854697GRCh37Chr 16, 68844245: 68844245

Cosmic variations for Gastric Cancer Risk After H. Pylori Infection:

8 (show top 50)    (show all 839)
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA Conf
1COSM20525STK26stomach,NS,carcinoma,adenocarcinomac.444C>Gp.A148A9
2COSM20551TRRAPstomach,NS,carcinoma,adenocarcinomac.5117G>Ap.R1706H9
3COSM1579018CDC42stomach,NS,carcinoma,adenocarcinomac.178+7A>Gp.?9
4COSM44091TP53stomach,NS,carcinoma,adenocarcinomac.746G>Ap.R249K9
5COSM44151TP53stomach,NS,carcinoma,adenocarcinomac.535C>Ap.H179N9
6COSM5279PTENstomach,NS,carcinoma,adenocarcinomac.610C>Ap.P204T9
7COSM760PIK3CAstomach,NS,carcinoma,adenocarcinomac.1624G>Ap.E542K9
8COSM4062177CDH1stomach,NS,carcinoma,adenocarcinomac.569A>Gp.Y190C9
9COSM767PIK3CAstomach,NS,carcinoma,adenocarcinomac.1637A>Cp.Q546P9
10COSM10648TP53stomach,NS,carcinoma,adenocarcinomac.524G>Ap.R175H9
11COSM5576263CDH1stomach,NS,carcinoma,adenocarcinomac.466T>Ap.W156R9
12COSM1716270AXIN1stomach,NS,carcinoma,adenocarcinomac.1591C>Ap.H531N9
13COSM10704TP53stomach,NS,carcinoma,adenocarcinomac.844C>Tp.R282W9
14COSM10656TP53stomach,NS,carcinoma,adenocarcinomac.742C>Tp.R248W9
15COSM5575863KMT2Cstomach,NS,carcinoma,adenocarcinomac.13602G>Cp.Q4534H9
16COSM5576251LRP1Bstomach,NS,carcinoma,adenocarcinomac.8269+2T>Cp.?9
17COSM10705TP53stomach,NS,carcinoma,adenocarcinomac.586C>Tp.R196*9
18COSM5576102ZNF521stomach,NS,carcinoma,adenocarcinomac.443G>Ap.C148Y9
19COSM5670CTNNB1stomach,NS,carcinoma,adenocarcinomac.101G>Tp.G34V9
20COSM5576226RETstomach,NS,carcinoma,adenocarcinomac.898G>Ap.D300N9
21COSM5576053NSD2stomach,NS,carcinoma,adenocarcinomac.3235G>Ap.A1079T9
22COSM10663TP53stomach,NS,carcinoma,adenocarcinomac.916C>Tp.R306*9
23COSM133015ARID1Astomach,NS,carcinoma,adenocarcinomac.5359G>Tp.E1787*9
24COSM266035ARID2stomach,NS,carcinoma,adenocarcinomac.925A>Gp.N309D9
25COSM43826TP53stomach,NS,carcinoma,adenocarcinomac.706T>Ap.Y236N9
26COSM521KRASstomach,NS,carcinoma,adenocarcinomac.35G>Ap.G12D9
27COSM5576192DICER1stomach,NS,carcinoma,adenocarcinomac.322C>Gp.Q108E9
28COSM5575994NUP214stomach,NS,carcinoma,adenocarcinomac.6140G>Tp.G2047V9
29COSM763PIK3CAstomach,NS,carcinoma,adenocarcinomac.1633G>Ap.E545K9
30COSM483HRASstomach,NS,carcinoma,adenocarcinomac.35G>Tp.G12V9
31COSM5575902PTPN11stomach,NS,carcinoma,adenocarcinomac.222G>Cp.L74F9
32COSM14062ERBB2stomach,NS,carcinoma,adenocarcinomac.2329G>Tp.V777L9
33COSM5575798MYH9stomach,NS,carcinoma,adenocarcinomac.5677C>Tp.R1893C9
34COSM11089TP53stomach,NS,carcinoma,adenocarcinomac.584T>Cp.I195T9
35COSM10709TP53stomach,NS,carcinoma,adenocarcinomac.722C>Gp.S241C9
36COSM685ERBB2stomach,NS,carcinoma,adenocarcinomac.2326G>Ap.G776S9
37COSM20569EPHA2stomach,NS,carcinoma,adenocarcinomac.2329G>Ap.G777S9
38COSM20537MLKLstomach,NS,carcinoma,adenocarcinomac.872T>Cp.L291P9
39COSM20558TGFBR2stomach,NS,carcinoma,adenocarcinomac.181T>Cp.C61R9
40COSM20550TRRAPstomach,NS,carcinoma,adenocarcinomac.477A>Gp.K159K9
41COSM20528TNK2stomach,NS,carcinoma,adenocarcinomac.1227G>Ap.M409I9
42COSM21289TEX14stomach,NS,carcinoma,adenocarcinomac.961G>Ap.E321K9
43COSM21278MLKLstomach,NS,carcinoma,adenocarcinomac.1192T>Ap.F398I9
44COSM5575620ADGRL3stomach,NS,carcinoma,adenocarcinomac.1023C>Ap.Y341*9
45COSM45620TP53stomach,NS,carcinoma,adenocarcinomac.704A>Cp.N235T9
46COSM5575913ERCC4stomach,NS,carcinoma,adenocarcinomac.2026G>Tp.E676*9
47COSM5575897ROS1stomach,NS,carcinoma,adenocarcinomac.89T>Ap.L30*9
48COSM14065ERBB2stomach,NS,carcinoma,adenocarcinomac.2524G>Ap.V842I9
49COSM5576132SETD2stomach,NS,carcinoma,adenocarcinomac.2168C>Ap.P723Q9
50COSM10735TP53stomach,NS,carcinoma,adenocarcinomac.638G>Ap.R213Q9

Copy number variations for Gastric Cancer Risk After H. Pylori Infection from CNVD:

6
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1133641196732869567426945DeletionCDH1hereditary diffuse gastric cancer

Expression for genes affiliated with Gastric Cancer Risk After H. Pylori Infection

About this section
Search GEO for disease gene expression data for Gastric Cancer Risk After H. Pylori Infection.

Pathways for genes affiliated with Gastric Cancer Risk After H. Pylori Infection

About this section

Pathways related to Gastric Cancer Risk After H. Pylori Infection according to GeneCards Suite gene sharing:

(show all 21)
idSuper pathwaysScoreTop Affiliating Genes
19.5CDH1, IL1B
29.5CDH1, CTNNA1
39.5CDH1, CTNNA1
49.5CDH1, CTNNA1
59.5CDH1, CTNNA1
69.5CDH1, CTNNA1
79.5CDH1, CTNNA1
89.5CDH1, CTNNA1
99.5CDH1, CTNNA1
109.5CDH1, CTNNA1
119.4CDH1, KRAS
129.4CDH1, KRAS
13
Show member pathways
8.9CDH1, IL1B, KRAS
14
Show member pathways
8.9CDH1, CTNNA1, KRAS
15
Show member pathways
8.9CDH1, CTNNA1, KRAS
168.9CDH1, CTNNA1, KRAS
17
Show member pathways
8.9IL1B, IL1RN, KRAS
188.7CDH1, CTNNA1, MAP3K6
19
Show member pathways
8.5IL1B, KRAS, MAP3K6
208.5IL1B, KRAS, MAP3K6
21
Show member pathways
8.4CDH1, CTNNA1, IL1B, KRAS

GO Terms for genes affiliated with Gastric Cancer Risk After H. Pylori Infection

About this section

Cellular components related to Gastric Cancer Risk After H. Pylori Infection according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1catenin complexGO:001634210.2CDH1, CTNNA1
2flotillin complexGO:001660010.2CDH1, CTNNA1
3focal adhesionGO:00059258.9CDH1, CTNNA1, KRAS

Biological processes related to Gastric Cancer Risk After H. Pylori Infection according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1adherens junction organizationGO:003433210.1CDH1, CTNNA1
2cellular response to indole-3-methanolGO:007168110.1CDH1, CTNNA1
3negative regulation of extrinsic apoptotic signaling pathway in absence of ligandGO:20012409.9CTNNA1, IL1B
4social behaviorGO:00351769.3IL1B, KRAS

Molecular functions related to Gastric Cancer Risk After H. Pylori Infection according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1beta-catenin bindingGO:00080139.8CDH1, CTNNA1
2gamma-catenin bindingGO:00452959.5CDH1, CTNNA1

Sources for Gastric Cancer Risk After H. Pylori Infection

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet